Come visit us at our booth in the Exhibit Hall (Booth #18104) at the 2019 ASCO Annual Meeting.
Check back often to see when some of our Editors-in-Chief, Board Members, and Cover Authors will be at our booth (Booth #18104):
Julie Vose, MD, MBA
Monday, June 3, 1:30 pm
Belzutifan Improves PFS Across Subgroups for Advanced ccRCC
July 12th 2024“In LITESPARK-005, PFS and response rates favored belzutifan vs everolimus across [several patient subgroups, including] IMDC risk, number of prior lines [of therapy], and number of prior VEGF TKIs, specifically,” said Laurence Albiges, MD, PhD.